Turnstone Biologics
2015
FOUNDED
PRIVATE
STATUS
21-30
EMPLOYEES
Series B
LATEST DEAL TYPE
$41.4M
LATEST DEAL AMOUNT
4
INVESTORS
Description
Developer of viral immunotherapies designed to improve survival for patients with cancer. The company's immunotherapies combine a bio-selected and engineered oncolytic virus to directly lyse tumors with a potent vaccine technology to drive tumor-antigen specific T-cell responses, enabling bio-medical professionals to generate immune responses, treat cancer and modulate tumor environment.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
- 787 Bank Street
- 2nd Floor
- Ottawa, Ontario K1S 3V5
- Canada
+1 (613) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Turnstone Biologics’s full profile, request a free trial.
Turnstone Biologics Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Early Stage VC (Series B) | 02-Nov-2016 | $41.4M | 000.00 | Completed | Generating Revenue | |
| 2. Early Stage VC (Series A) | 28-Oct-2015 | 000.00 | 000.00 | Completed | Startup | |
| 1. Angel (individual) | 04-May-2015 | Completed | Startup |
Turnstone Biologics Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| F-Prime Capital Partners | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| OrbiMed | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Versant Venture Management | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Fight Against Cancer Innovation Trust | Other | Minority | 000 0000 | 000000 0 |
Turnstone Biologics Executive Team (12)
1 Former Executive
You’re viewing 5 of 12 executives. Get the full list »Turnstone Biologics Board Members (7)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Ben Auspitz | F-Prime Capital Partners | Board Member | 000 0000 | |
| Bradley Bolzon Ph.D | Versant Venture Management | Chairman | 000 0000 | |
| Jeff Courtney | Fight Against Cancer Innovation Trust | Board Member | 000 0000 | |
| Jerel Davis Ph.D | Versant Venture Management | Board Member | 000 0000 | |
| John Bell Ph.D | Self | Co-Founder & Board Member | 000 0000 |